MacroGenics
MGNX
#8794
Rank
A$0.34 B
Marketcap
A$5.35
Share price
5.35%
Change (1 day)
105.04%
Change (1 year)

MacroGenics (MGNX) - Net assets

Net assets on the balance sheet as of June 2026 : A$61.35 Million

According to MacroGenics's latest financial reports the company has A$61.35 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

MacroGenics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$82.99 M-55.52%
2024-12-31$A$0.18 B-16.7%
2023-12-31$A$0.22 B7.34%
2022-12-31$A$0.20 B-36.86%
2021-12-31$A$0.33 B-14.11%
2020-12-31$A$0.38 B16.82%
2019-12-31$A$0.32 B-4.46%
2018-12-31$A$0.34 B-10.05%
2017-12-31$A$0.38 B2.8%
2016-12-31$A$0.37 B-13.32%
2015-12-31$A$0.43 B190.23%
2014-12-31$A$0.14 B67.51%
2013-12-31$A$88.47 M-1216.12%
2012-12-31$-A$7.93 Million-53.52%
2011-12-31$-A$17.06 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
A$122.34 B 199,307.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$48.48 B 78,921.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$16.72 B 27,161.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$16.80 B 27,292.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$60.08 B 97,826.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$31.94 B 51,958.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.72 B 1,073.76%๐Ÿ‡บ๐Ÿ‡ธ USA